Skip to main content

Cancer Care Business Exchange

The Cancer Care Business Exchange is a high-level, multistakeholder forum that focuses on the business implications of the changing complexities in cancer care delivery and payment.
Cancer Care Business Breakthroughs

BDHC thumbnail
Videos
09/16/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the many dimensions of second opinions in oncology—ranging from in-practice consultations to academic referrals, payer-sponsored programs, and...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the many dimensions of second opinions in oncology—ranging from in-practice consultations to academic referrals, payer-sponsored programs, and...
In this episode of Breaking Down...
09/16/2025
Cancer Care Business Exchange
CPC+CBEx SESSION TEASERS
08/15/2025
Barbara McAneny, MD
Drug prices are the focus of many people in health care, but no one is measuring the total cost of delivering the drugs to the patient. Getting a patient through chemotherapy requires attention to their side effects and toxicities, and their...
Drug prices are the focus of many people in health care, but no one is measuring the total cost of delivering the drugs to the patient. Getting a patient through chemotherapy requires attention to their side effects and toxicities, and their...
Drug prices are the focus of...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
08/15/2025
Carole Tremonti, RN, MBA
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology treatment has been at the forefront of oncology decision-making for over 20 years, yet the methods in which we evaluate and select regimens for a pathway has remained the same. Within our community, we have all...
Decision support for oncology...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
08/15/2025
Dan Nardi
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully integrated combination of clinical teams and scalable, [artificial intelligence] technology can enable around-the-clock patient support, reinforce adherence to evidence-based clinical pathways, and extend high-quality...
Learn how a thoughtfully...
08/15/2025
Journal of Clinical Pathways
CPC+CBEx SESSION TEASERS
08/15/2025
Stephen Speicher, MD, MS
Artificial intelligence (AI) is not a future concept in oncology—it’s here, integrated into daily workflows and documentation at the point of care. But with that progress comes a new set of questions: Are we implementing AI in a way that...
Artificial intelligence (AI) is not a future concept in oncology—it’s here, integrated into daily workflows and documentation at the point of care. But with that progress comes a new set of questions: Are we implementing AI in a way that...
Artificial intelligence (AI) is...
08/15/2025
Journal of Clinical Pathways
BDHC thumbnail
Videos
08/04/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej explore the undervalued yet critical role of primary care in the health care ecosystem—especially in oncology—highlighting its impact on early detection,...
In this episode of Breaking Down...
08/04/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
06/11/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down Health Care, John Hennessy and Dr. Michael Kolodziej explore the limitations of current medical education—from outdated testing and board certification to gaps in real-world practice preparedness—and call for...
In this edition of Breaking Down...
06/11/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
05/05/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej discuss the evolution of remote patient engagement in oncology—from the rapid expansion of telemedicine during COVID-19 to the growing role of tools like...
In this episode of Breaking Down Health Care, John Hennessy and Dr Michael Kolodziej discuss the evolution of remote patient engagement in oncology—from the rapid expansion of telemedicine during COVID-19 to the growing role of tools like...
In this episode of Breaking Down...
05/05/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
04/07/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Dr Michael Kolodziej, MD, explore the complex and evolving role of private equity in health care, weighing its potential to drive innovation and efficiency against concerns...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Dr Michael Kolodziej, MD, explore the complex and evolving role of private equity in health care, weighing its potential to drive innovation and efficiency against concerns...
In this episode of Breaking Down...
04/07/2025
Cancer Care Business Exchange
BDHC Thumbnail
Videos
02/28/2025
John Hennessy, MBA; Michael Kolodziej, MD
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down Health Care, John Hennessy, MBA, and Michael Kolodziej, MD, explore the evolving landscape of oncology clinical trials, discussing the challenges of patient enrollment, the impact of pharmaceutical-sponsored...
In this episode of Breaking Down...
02/28/2025
Cancer Care Business Exchange